Last reviewed 2026-04-20 · How we verify

Kemadrine (PROCYCLIDINE)

FDA-approved approved Small molecule Quality 25/100

At a glance

Generic name	PROCYCLIDINE
Target	Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1955

Approved indications

Arteriosclerotic Parkinsonism
Extrapyramidal disease
Parkinson's disease
Parkinsonism
Postencephalitic parkinsonism

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions